drugset / Trial / NCT04005053

Signatures of N-Ac for Non-Suicidal Self-Injury in Adolescents

NCT04005053

Phase 2 Completed 44 enrolled University of Minnesota
RandomizedParallel-groupTriple-blindTreatment

Summary

To measure NAC-induced changes to concentrations of glutathione (GSH) in the anterior cingulate cortex (ACC) as measured by magnetic resonance spectroscopy (MRS) in 36 adolescents and young adults with NSSI (12 in each group: high, low, and placebo).

Timeline

Start
2019-08-01
Primary completion
2022-05-08
Completion
2022-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 3600 mg Oral
Subject N-acetylcysteine Small molecule 5400 mg Oral

Indications